These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18184138)

  • 21. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract.
    Yantiss RK; Odze RD
    Am J Gastroenterol; 2009 Mar; 104(3):774-83. PubMed ID: 19209164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic features are useful in distinguishing Barrett esophagus from carditis with intestinal metaplasia.
    Srivastava A; Odze RD; Lauwers GY; Redston M; Antonioli DA; Glickman JN
    Am J Surg Pathol; 2007 Nov; 31(11):1733-41. PubMed ID: 18059231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconsidering Barrett's esophagus: practical applications of biophotonics.
    Wolfsen HC; Wallace MB
    Gastroenterology; 2008 Feb; 134(2):382-5. PubMed ID: 18242204
    [No Abstract]   [Full Text] [Related]  

  • 24. Intestinal metaplasia of cardiac mucosa and its immunostaining characteristics.
    Mouzas IA; Jovanovic I
    Am J Gastroenterol; 2003 Jul; 98(7):1653-4; author reply 1654-6. PubMed ID: 12873597
    [No Abstract]   [Full Text] [Related]  

  • 25. What's new in columnar lined esophagus (Barrett's metaplasia)?
    Tadiparthi R; Bansal A; Sharma P
    Curr Opin Gastroenterol; 2008 Jul; 24(4):516-20. PubMed ID: 18622169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histology of metaplasia and dysplasia in Barrett's esophagus.
    Yerian L
    Surg Oncol Clin N Am; 2009 Jul; 18(3):411-22. PubMed ID: 19500733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal or gastric? The unsolved dilemma of Barrett's metaplasia.
    Rugge M; Fassan M; Battaglia G; Parente P; Zaninotto G; Ancona E
    Hum Pathol; 2009 Aug; 40(8):1206-7; author reply 1207-8. PubMed ID: 19616698
    [No Abstract]   [Full Text] [Related]  

  • 28. Cytokeratin immunoreactivity of intestinal metaplasia.
    Mouzas IA; Jovanovic I; Milosavljevic T; Tzardi M; Kanavaros P
    Gut; 2002 Dec; 51(6):894-5; author reply 895. PubMed ID: 12427798
    [No Abstract]   [Full Text] [Related]  

  • 29. Variability in the interpretations of endoscopic findings in patients with intestinal transplantation.
    Tabasco-Minguillán J; Weber K; Nelson F; Hutson W; Furukawa H; Abu-Elmagd K; Todo S; Rakela J
    Transplant Proc; 1996 Oct; 28(5):2775-6. PubMed ID: 8908053
    [No Abstract]   [Full Text] [Related]  

  • 30. Questions regarding surgery to correct short-segment BE: comment on "Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus".
    DeMeester SR
    Arch Surg; 2009 Oct; 144(10):927. PubMed ID: 19852100
    [No Abstract]   [Full Text] [Related]  

  • 31. Autofluorescence endoscopy.
    Falk GW
    Gastrointest Endosc Clin N Am; 2009 Apr; 19(2):209-20. PubMed ID: 19423019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up.
    Fleischer DE; Overholt BF; Sharma VK; Reymunde A; Kimmey MB; Chuttani R; Chang KJ; Lightdale CJ; Santiago N; Pleskow DK; Dean PJ; Wang KK
    Gastrointest Endosc; 2008 Nov; 68(5):867-76. PubMed ID: 18561930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and distribution of gastric intestinal metaplasia and its subtypes.
    Eriksson NK; Kärkkäinen PA; Färkkilä MA; Arkkila PE
    Dig Liver Dis; 2008 May; 40(5):355-60. PubMed ID: 18291729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Esophageal radiofrequency ablation for the treatment of intestinal metaplasia, low grade dysplasia, and high grade dysplasia.
    Force SD; Miller DL
    Semin Thorac Cardiovasc Surg; 2008; 20(4):305-9. PubMed ID: 19251169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In praise of folly: the Erasmus score for intestinal metaplasia.
    Genta RM
    Gastrointest Endosc; 2009 Jul; 70(1):26-8. PubMed ID: 19559831
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic difficulties in Barrett mucosa. Borderline forms of Barrett esophagus].
    Potet F
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D13-6. PubMed ID: 8013774
    [No Abstract]   [Full Text] [Related]  

  • 38. Current application of confocal endomicroscopy in gastrointestinal disorders.
    Nguyen NQ; Leong RW
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1483-91. PubMed ID: 18761561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
    Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis.
    Ngamruengphong S; Sharma VK; Das A
    Gastrointest Endosc; 2009 May; 69(6):1021-8. PubMed ID: 19215918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.